Methylation of PTCH1, the Patched-1 gene, in a panel of primary medulloblastomas

Joel I Pritchard1, James M Olson

  • 1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

Insights

This study investigated PTCH1 promoter methylation in pediatric medulloblastoma (MB). Contrary to hypotheses, no PTCH1 promoter methylation was found in MB tumors, suggesting other mechanisms are involved in Shh pathway dysregulation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The Sonic hedgehog (Shh) pathway is frequently activated in medulloblastoma (MB), a common pediatric brain tumor.
  • PTCH1 acts as a tumor suppressor and negative regulator of the Shh pathway; its silencing via promoter methylation is a potential mechanism in tumorigenesis.

Purpose of the Study:

  • To investigate the methylation status of the PTCH1 gene's proximal promoter (variant exon 1B) in medulloblastoma.
  • To determine if PTCH1 promoter methylation contributes to Shh pathway dysregulation in MB cases with high pathway activity.

Main Methods:

  • Analysis of 21 primary medulloblastoma samples and 5 pediatric cerebellum controls.
  • Selection of MB cases based on high expression of Shh pathway indicators (GLI1, MYCN) and low PTCH1 expression.
  • Bisulfite sequencing was used to assess methylation profiles of the PTCH1-1B promoter.

Main Results:

  • No evidence of methylation was detected in the PTCH1-1B promoter in any of the examined medulloblastoma cases.
  • Similarly, no methylation was observed in the PTCH1-1B promoter of control cerebellum samples.
  • These findings contradict the hypothesis that PTCH1 promoter methylation silences the gene in MB.

Conclusions:

  • PTCH1 promoter methylation (variant exon 1B) is not a significant mechanism for Shh pathway dysregulation in the studied medulloblastoma cohort.
  • Further research should explore methylation in distal PTCH1 promoter regions and alternative exon variants, such as the PTCH1-1C promoter.